| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.002 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.006 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |